| pubmed-article:21646962 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21646962 | lifeskim:mentions | umls-concept:C0032659 | lld:lifeskim |
| pubmed-article:21646962 | lifeskim:mentions | umls-concept:C0012634 | lld:lifeskim |
| pubmed-article:21646962 | lifeskim:mentions | umls-concept:C0305065 | lld:lifeskim |
| pubmed-article:21646962 | lifeskim:mentions | umls-concept:C0205281 | lld:lifeskim |
| pubmed-article:21646962 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:21646962 | lifeskim:mentions | umls-concept:C0449943 | lld:lifeskim |
| pubmed-article:21646962 | lifeskim:mentions | umls-concept:C1519885 | lld:lifeskim |
| pubmed-article:21646962 | lifeskim:mentions | umls-concept:C0678227 | lld:lifeskim |
| pubmed-article:21646962 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:21646962 | pubmed:dateCreated | 2011-6-7 | lld:pubmed |
| pubmed-article:21646962 | pubmed:abstractText | Before the introduction of the heptavalent pneumococcal conjugate vaccine (Prevnar-7), the relative prevalence of serotypes of Streptococcus pneumoniae was fairly stable worldwide. We sought to develop a statistical tool to predict the relative frequency of different serotypes among disease isolates in the pre- and post-Prevnar-7 eras using the limited amount of data that is widely available. | lld:pubmed |
| pubmed-article:21646962 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21646962 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21646962 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21646962 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21646962 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21646962 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21646962 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21646962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21646962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21646962 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21646962 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:21646962 | pubmed:issn | 1531-5487 | lld:pubmed |
| pubmed-article:21646962 | pubmed:author | pubmed-author:LipsitchMarcM | lld:pubmed |
| pubmed-article:21646962 | pubmed:author | pubmed-author:ScottJ... | lld:pubmed |
| pubmed-article:21646962 | pubmed:author | pubmed-author:WeinbergerDan... | lld:pubmed |
| pubmed-article:21646962 | pubmed:author | pubmed-author:HarboeZitta... | lld:pubmed |
| pubmed-article:21646962 | pubmed:author | pubmed-author:FlascheStefan... | lld:pubmed |
| pubmed-article:21646962 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21646962 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:21646962 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21646962 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21646962 | pubmed:pagination | 199-207 | lld:pubmed |
| pubmed-article:21646962 | pubmed:meshHeading | pubmed-meshheading:21646962... | lld:pubmed |
| pubmed-article:21646962 | pubmed:meshHeading | pubmed-meshheading:21646962... | lld:pubmed |
| pubmed-article:21646962 | pubmed:meshHeading | pubmed-meshheading:21646962... | lld:pubmed |
| pubmed-article:21646962 | pubmed:meshHeading | pubmed-meshheading:21646962... | lld:pubmed |
| pubmed-article:21646962 | pubmed:meshHeading | pubmed-meshheading:21646962... | lld:pubmed |
| pubmed-article:21646962 | pubmed:meshHeading | pubmed-meshheading:21646962... | lld:pubmed |
| pubmed-article:21646962 | pubmed:meshHeading | pubmed-meshheading:21646962... | lld:pubmed |
| pubmed-article:21646962 | pubmed:meshHeading | pubmed-meshheading:21646962... | lld:pubmed |
| pubmed-article:21646962 | pubmed:meshHeading | pubmed-meshheading:21646962... | lld:pubmed |
| pubmed-article:21646962 | pubmed:meshHeading | pubmed-meshheading:21646962... | lld:pubmed |
| pubmed-article:21646962 | pubmed:meshHeading | pubmed-meshheading:21646962... | lld:pubmed |
| pubmed-article:21646962 | pubmed:meshHeading | pubmed-meshheading:21646962... | lld:pubmed |
| pubmed-article:21646962 | pubmed:meshHeading | pubmed-meshheading:21646962... | lld:pubmed |
| pubmed-article:21646962 | pubmed:meshHeading | pubmed-meshheading:21646962... | lld:pubmed |
| pubmed-article:21646962 | pubmed:meshHeading | pubmed-meshheading:21646962... | lld:pubmed |
| pubmed-article:21646962 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21646962 | pubmed:articleTitle | Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations. | lld:pubmed |
| pubmed-article:21646962 | pubmed:affiliation | Department of Immunology and Infectious Diseases, Harvard School of Public Health, 665 Huntington Ave, Boston, MA 02115, USA. dweinber@gmail.com | lld:pubmed |
| pubmed-article:21646962 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21646962 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:21646962 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
